Search Results - "Kichula, Elizabeth"
-
1
Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy
Published in Muscle & nerve (01-10-2021)“…Spinal muscular atrophy (SMA) is an autosomal recessive, neurodegenerative disease caused by biallelic mutations in the survival motor neuron 1 (SMN1) gene…”
Get full text
Journal Article -
2
Clinical Experience With Gene Therapy in Older Patients With Spinal Muscular Atrophy
Published in Pediatric neurology (01-05-2021)“…Onasemnogene abeparvovec was recently approved for the treatment of spinal muscular atrophy (SMA) in children younger than two years; however, clinical trials…”
Get full text
Journal Article -
3
Clinical Course in a Patient With Spinal Muscular Atrophy Type 0 Treated With Nusinersen and Onasemnogene Abeparvovec
Published in Journal of child neurology (01-10-2020)“…Spinal muscular atrophy type 0 is the most severe phenotype of the disease, with patients presenting with contractures, weakness, and respiratory failure at…”
Get full text
Journal Article -
4
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study
Published in Neurology (26-01-2021)“…To describe the respiratory trajectories and their correlation with motor function in an international pediatric cohort of patients with type 2 and nonambulant…”
Get full text
Journal Article -
5
Patient headache questionnaires can improve headache diagnosis and treatment in children
Published in Headache (01-11-2023)“…Objective To examine trends in diagnosis of headache and migraine in a large pediatric neurology cohort, and test whether an electronic health record…”
Get full text
Journal Article -
6
Developmental and comparative aspects of posterior medial thalamocortical innervation of the barrel cortex in mice and rats
Published in Journal of comparative neurology (1911) (20-07-2008)“…The thalamocortical projection to the rodent barrel cortex consists of inputs from the ventral posterior medial (VPM) and posterior medial (POm) nuclei that…”
Get full text
Journal Article -
7
A multidisciplinary approach to dosing nusinersen for spinal muscular atrophy
Published in Neurology. Clinical practice (01-10-2019)“…In December 2016, nusinersen gained FDA approval as the first pharmacologic treatment for spinal muscular atrophy (SMA), a disorder of motor neurons and the…”
Get full text
Journal Article -
8
Familial Dysautonomia Is Caused by Mutations of the IKAP Gene
Published in American journal of human genetics (01-03-2001)“…The defective gene DYS, which is responsible for familial dysautonomia (FD) and has been mapped to a 0.5-cM region on chromosome 9q31, has eluded…”
Get full text
Journal Article -
9
Early Clinical Experience with Onasemnogene Abeparvovec in Spinal Muscular Atrophy (SMA) Type 2 Patients at a Single Center (4855)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
10
Etravirine in Friedreich's ataxia: Lessons from HIV?
Published in Movement disorders (01-03-2019)Get full text
Journal Article -
11
Frataxin Restoration in the Nervous System: Possibilities for Gene Therapy
Published in Molecular therapy (01-08-2018)“…[...]this approach provides a rationale at the level of frataxin expression for one component of the selective neuronal vulnerability in FRDA. [...]this model…”
Get full text
Journal Article -
12
Challenges ahead for trials in Friedreich’s ataxia
Published in Lancet neurology (01-12-2016)“…The disorder results from expansion of GAA repeats in the FXN gene, which leads to deficiency of frataxin, a small protein that is thought to be required for…”
Get full text
Journal Article -
13
Motor Outcomes after Clinical Treatment with Nusinersen: A Single-center Experience (P1.6-053)
Published in Neurology (09-04-2019)“…Abstract only…”
Get full text
Journal Article -
14
Structural Cardiac Malformations in Spinal Muscular Atrophy; A Case Series (1632)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
15
CSF Biomarkers of Disease Severity and Response to Nusinersen Treatment in Children with Spinal Muscular Atrophy (1971)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
16
Effect of Nusinsersen in an Adult SMA Cohort: CSF Biomarkers and RULM (4725)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
17
Inherited Neuromuscular Disorders: Presentation, Diagnosis, and Advances in Treatment
Published in Current pediatrics reports (Philadelphia, PA) (01-03-2017)“…Purpose of Review This article reviews presentation of inherited neuromuscular disorders, including how to differentiate them from other causes of hypotonia…”
Get full text
Journal Article -
18
Friedreich Ataxia: Multidisciplinary Clinical Care
Published in Journal of multidisciplinary healthcare (01-01-2021)“…Friedreich ataxia (FRDA) is a multisystem disorder affecting 1 in 50,000-100,000 person in the United States. Traditionally viewed as a neurodegenerative…”
Get full text
Journal Article -
19
Outcomes of early‐treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study
Published in Muscle & nerve (01-12-2024)“…Introduction/Aims While prompt identification and treatment of infants with spinal muscular atrophy (SMA) can ameliorate outcomes, variability persists. This…”
Get full text
Journal Article -
20
Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) Feasibility for Individuals with Severe Spinal Muscular Atrophy II (S46.004)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article